Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01311102 · ClinicalTrials.gov registry record · Phase 4
The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement
A Phase 4 study, sponsored by Women's Health Care Clinic, Torrance, California.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01311102 is a Phase 4 study that has completed, run by Women's Health Care Clinic, Torrance, California. The registered enrollment target is 40 participants.
The verdict
NCT01311102, a Phase 4 study, has completed, sponsored by Women's Health Care Clinic, Torrance, California.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The study hypothesis is that infusion of 2% lidocaine at the time of IUD placement will reduce pain scores related to that procedure. In a double blinded randomized trial of 60 women receiving either normal saline or lidocaine infused through an endometrial aspirator, pain scores will be obtained for each step of the IUD placement procedure and for the total experience.
Interventions
- DRUG Lidocaine
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01311102
The ClinicalTrials.gov registry entry for NCT01311102 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Women's Health Care Clinic, Torrance, California, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT01311102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01311102 about?
NCT01311102 is a clinical study titled "The Impact of Pain Scores on Intrauterine Lidocaine Versus Normal Saline Infusion at the Time of IUD Placement". The study hypothesis is that infusion of 2% lidocaine at the time of IUD placement will reduce pain scores related to that procedure. In a double blinded randomized trial of 60 women receiving either normal saline or lidocaine infused through an endometrial aspirator, pain scores will be obtained fo...
What is the current status of trial NCT01311102?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2008-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01311102?
The interventions under investigation include: Lidocaine (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01311102?
This trial is sponsored by Women's Health Care Clinic, Torrance, California, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.